Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Sales $ 340,360 $ 117,332 $ 615,399 $ 414,318
Cost of sales (280,100) (241,205) (439,566) (490,626)
Gross profit (loss) 60,260 (123,873) 175,833 (76,308)
Operating Expenses        
Selling and marketing 118,695 12,106 235,211 49,999
General and administrative 1,205,633 1,253,038 2,563,630 2,482,273
Depreciation and amortization 30,992 46,342 67,922 92,503
Total operating expenses 1,355,320 1,311,486 2,866,763 2,624,775
Loss from Operations (1,295,060) (1,435,359) (2,690,930) (2,701,083)
Other Expense (Income)        
Interest expense, net 32,584 90,903 38,563 121,136
Forgiveness of PPP Loan (242,486)
Gains from foreign currency translation (9,858) (20,025) (28,861) (20,490)
Total other expense (income) 22,726 70,878 (232,784) 100,646
Net Loss (1,317,786) (1,506,237) (2,458,146) (2,801,729)
Net loss attributable to non-controlling interest 70,052 52,872 97,561 95,517
Series B preferred stock dividends (182,353) (362,123)
Net Loss Attributable to Common Stockholders $ (1,247,734) $ (1,635,718) $ (2,360,585) $ (3,068,335)
Net Loss per Common Share $ (0.16) $ (0.41) $ (0.34) $ (0.76)
Weighted Average Number of Common Shares Outstanding:        
Basic and Diluted 7,565,530 4,018,101 6,957,709 4,018,101